Form 4: IN8BIO Director Alan S. Roemer Acquires Stock Options
SEC Form 4 Filing
Director Alan S. Roemer of IN8BIO, INC. reports the acquisition of stock options.
Summary
- On May 8, 2025, Alan S. Roemer, a director of IN8BIO, INC., acquired stock options to purchase 63,150 shares of common stock at an exercise price of $0.17 per share.
- The options vest in equal monthly installments starting June 8, 2025, with full vesting by the date of the company's next annual meeting of stockholders, contingent on continued service.
- Following the transaction, Roemer directly owns 63,150 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine disclosure of stock option grants to a director.
Positives
- The acquisition of stock options by a director signals confidence in the company's future performance.
Industry Context
This is a standard disclosure related to insider transactions, common in publicly traded companies to ensure transparency.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.
Key Dates
| Date | Description |
|---|---|
| 05/08/2025 | Date of the stock option transaction. |
| 06/08/2025 | Vesting of stock options begins in monthly installments. |
| 05/12/2025 | Date of the Form 4 filing. |
Keywords
IN8BIO, Director, Stock Options, Form 4, Beneficial Ownership, Alan S. Roemer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.